These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 16132578)
21. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity. Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768 [TBL] [Abstract][Full Text] [Related]
22. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Ambartsumian NS; Grigorian MS; Larsen IF; Karlstrøm O; Sidenius N; Rygaard J; Georgiev G; Lukanidin E Oncogene; 1996 Oct; 13(8):1621-30. PubMed ID: 8895507 [TBL] [Abstract][Full Text] [Related]
23. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Scheiber MN; Watson PM; Rumboldt T; Stanley C; Wilson RC; Findlay VJ; Anderson PE; Watson DK Neoplasia; 2014 Oct; 16(10):801-13. PubMed ID: 25379017 [TBL] [Abstract][Full Text] [Related]
24. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574 [TBL] [Abstract][Full Text] [Related]
25. Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice. Wong PS; Matsumura F BMC Cancer; 2007 Jul; 7():130. PubMed ID: 17640349 [TBL] [Abstract][Full Text] [Related]
27. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138 [TBL] [Abstract][Full Text] [Related]
28. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor. Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093 [TBL] [Abstract][Full Text] [Related]
29. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Jessen KA; Liu SY; Tepper CG; Karrim J; McGoldrick ET; Rosner A; Munn RJ; Young LJ; Borowsky AD; Cardiff RD; Gregg JP Breast Cancer Res; 2004; 6(3):R157-69. PubMed ID: 15084239 [TBL] [Abstract][Full Text] [Related]
32. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287 [TBL] [Abstract][Full Text] [Related]
33. Autocrine PDGFR signaling promotes mammary cancer metastasis. Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576 [TBL] [Abstract][Full Text] [Related]
35. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
36. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874 [TBL] [Abstract][Full Text] [Related]
37. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527 [TBL] [Abstract][Full Text] [Related]
38. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
39. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
40. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth. Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]